Intrathecal dexamethasone therapy for febrile infection‐related epilepsy syndrome

Abstract

IT-DEX represents a therapeutic option for patients with FIRES that could shorten the duration of the critical stage of the disease. The effect of IT-DEX on FIRES might include cytokine-independent mechanisms.